+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

CD (Cluster of Differentiation) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD (Cluster of Differentiation) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Histone deacetylase (HDAC) Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Matrix Metalloproteinase (MMP) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
Akt1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Akt1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 120 Pages
  • Global
From
CCR1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CD40 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

CD40 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
HIF-1 Alpha Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

HIF-1 Alpha Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Alpha-1 Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Alpha-1 Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Wnt Signaling Pathway Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Angiopoietin Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Angiopoietin Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
STAT Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

STAT Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 150 Pages
  • Global
From
20s Proteasome Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

20s Proteasome Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
CD 19 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CD 19 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
G2 Checkpoint Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

G2 Checkpoint Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
CCR4 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CCR4 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Prolactin Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Prolactin Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
TGF-Beta-1 Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

TGF-Beta-1 Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

PI3K/mTOR Pathway Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more